334728
Major depression: Effect on self-care behavior of adults with diabetes
Objectives: to assess effect of MD on diabetes self-care according to CDA recommendations.
Study sample: The analysis was conducted using the 2007-08 Canadian Community Health Survey data. In addition to core survey, modules on depression and diabetes care were administered in health regions of Nova Scotia and New Brunswick. The final study sample contained 932 adults with non-gestational diabetes.
Results: The rate of MD was almost 3 times higher among females than males (11.2% versus 3.5%). By age group, the highest percentage of MD was among adults 30-39 year old (23.6%). More than half of study participants in each demographic subgroup were noncompliant with the guidelines. Males were less likely to be compliant than females (57.5% and 54.3%). MD was significantly associated with increased rate of noncompliance (OR=1.76; 95% CI =1.02; 3.32) after adjusting for age, sex, and education. Although females had higher prevalence of MD compared with males, being a female had a protective effect against noncompliance in patients with diabetes type II.
Conclusion: Major depression almost doubled the rate of noncompliance with self-care practices recommended by CDA guidelines. Major depression should be considered by health practitioners as the key challenge in diabetes self-care and depression management must be taken into account for healthcare planning to prevent diabetes complications.
Learning Areas:
Chronic disease management and preventionEpidemiology
Public health or related education
Public health or related research
Learning Objectives:
Identify distribution of MD among patients with diabetes Type II
Assess effect of MD on diabetes self-care according to CDA recommendations
Discuss disparities in prevalence of major depression and self-care compliance
Keyword(s): Depression, Diabetes
Qualified on the content I am responsible for because: I conducted the data analysis and wrote the abstract.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.